Bayesian Epigenome-Wide Association Study in Educational Research
Bayesian Epigenome-Wide Association Study Applied to Educational Research Outcomes · Also known as: Bayesian EWAS, Bayesian epigenome-wide scan, Bayesian methylation-wide association study, B-EWAS
A Bayesian epigenome-wide association study (Bayesian EWAS) scans hundreds of thousands of DNA methylation sites across the genome to identify those statistically associated with an educational outcome — such as cognitive ability, attainment, or socioeconomic exposure during schooling. Unlike classical frequentist EWAS, the Bayesian framework incorporates prior biological knowledge to compute posterior probabilities of association, improving power and reducing false discoveries when applied to complex educational phenotypes.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use Bayesian EWAS in educational research when you have a population-based cohort with both genome-wide DNA methylation data (450K or EPIC array) and well-measured educational outcomes or exposures (e.g., years of schooling, cognitive test scores, school readiness, socioeconomic status). The Bayesian framework is particularly valuable when sample sizes are modest (n < 500) and biological prior knowledge can compensate for limited statistical power, or when you want calibrated probability estimates rather than binary p-value thresholds. Do not use this method if your data lack methylation arrays or if you are working with small clinical samples lacking replication; frequentist EWAS with established correction (Bonferroni, FDR) is more transparent in well-powered large-cohort settings. Avoid applying EWAS to cross-sectional data when causal inference about education-epigenome directionality is the goal — pair findings with Mendelian randomization or longitudinal designs.
Strengths & limitations
- Posterior inclusion probabilities give an interpretable probability-scale measure of association, avoiding the binary reject/fail-to-reject logic of p-values.
- Incorporation of biological priors (genomic annotation, pathway databases) increases power to detect true signals in modest-sized educational cohorts.
- Sparsity-inducing priors (spike-and-slab, horseshoe) naturally handle the high-dimensional problem of testing hundreds of thousands of CpG sites simultaneously.
- Produces full posterior distributions over effect sizes, enabling richer uncertainty quantification relevant for translational or policy-relevant interpretation.
- Coherent framework for integrating multiple omics layers (methylation + gene expression) via Bayesian multi-omics models.
- Computationally expensive: full MCMC over 450,000 sites requires substantial time and high-performance computing; approximations (variational Bayes) introduce their own biases.
- Prior choice is consequential — misspecified priors can inflate or deflate posterior probabilities, and sensitivity analyses across prior settings are rarely reported in practice.
- Replication across independent cohorts remains the critical validity check; Bayesian estimates from a single cohort should not be overinterpreted as definitive.
- Cell-type deconvolution in blood-based samples is imperfect; residual cellular heterogeneity can confound associations with educational phenotypes.
- Educational phenotypes are complex, often measured with error, and subject to confounding by socioeconomic factors that also influence methylation — causal interpretation requires additional designs.
Frequently asked
How is Bayesian EWAS different from a standard (frequentist) EWAS?
Standard EWAS fits a linear or logistic regression at each CpG site and reports p-values with Bonferroni or FDR correction. Bayesian EWAS instead computes a posterior probability of association (posterior inclusion probability, PIP) for each site, incorporating prior biological knowledge. This makes the Bayesian version more powerful in modest samples where priors can guide the analysis, and produces probability-scale summaries that are easier to interpret than thresholded p-values.
What sample size is needed for a Bayesian EWAS in an educational cohort?
There is no universal minimum. Frequentist EWAS typically requires several hundred to thousands of participants to achieve genome-wide significance after multiple testing correction. Bayesian approaches can operate in smaller samples by leveraging priors, but findings from cohorts under 200 participants should be treated with caution and validated in independent data. Large population cohorts (n > 500, ideally > 1000) with high-quality educational phenotypes yield the most reliable results.
Can I apply Bayesian EWAS to saliva or buccal cell DNA rather than blood?
Yes. Saliva and buccal cells are more practical to collect in school-based research. However, cell-type composition differs from blood and deconvolution reference panels are less mature for these tissues. Methylation patterns also differ by tissue, so blood-based reference EWAS results may not replicate in saliva data and vice versa. Tissue-matched reference panels and careful cell-type adjustment are essential.
Does a significant EWAS hit mean education causes the methylation change?
No. A significant EWAS association is observational — it shows that methylation at a given site is correlated with the educational variable, but does not establish the direction of causation. Educational exposures and methylation can be mutually influenced by shared socioeconomic or genetic confounders. Causal inference requires additional designs such as Mendelian randomization, longitudinal pre-post studies with educational interventions, or natural experiments.
Which software is commonly used for Bayesian EWAS?
R is the dominant platform. Packages such as BayesEWAS, JAGS (via rjags), Stan (via RStan or brms), and the BSMM package support Bayesian methylation-wide analyses. For preprocessing, minfi, ChAMP, and ENmix handle normalisation and quality control of Illumina array data. Cell-type deconvolution typically uses the minfi or EpiDISH packages.
Sources
- Rakyan, V. K., Down, T. A., Balding, D. J., & Beck, S. (2011). Epigenome-wide association studies for common human diseases. Nature Reviews Genetics, 12(8), 529–541. link ↗
- Ligthart, S., Marzi, C., Aslibekyan, S., Mendelson, M. M., Conneely, K. N., Tanaka, T., ... & Dehghan, A. (2016). DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases. Genome Biology, 17(1), 255. link ↗
How to cite this page
ScholarGate. (2026, June 3). Bayesian Epigenome-Wide Association Study Applied to Educational Research Outcomes. ScholarGate. https://scholargate.app/en/bioinformatics/bayesian-epigenome-wide-association-study-in-educational-research
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Epigenetic Clock (DNA Methylation Age)Social Gerontology↔ compare
- Genome-wide association studyBioinformatics↔ compare
- Mediation AnalysisStatistics↔ compare
- Mendelian RandomizationCausal inference↔ compare